LINHAI TIANYU PHARMACEUTICAL CO LTD

Overview

LINHAI TIANYU PHARMACEUTICAL CO LTD is an active pharmaceutical ingredient (API) supplier with 11 active FDA Type II Drug Master Files, covering APIXABAN; AZILSARTAN; AZILSARTAN KAMEDOXOMIL; DAPAGLIFLOZIN; FEBUXOSTAT; MONTELUKAST BACKONE DIOL.

Core services & business areas

Active pharmaceutical ingredients supplied

Substances LINHAI TIANYU PHARMACEUTICAL CO LTD is evidenced to supply (US FDA Drug Master File or EU CEP). Open any ingredient to see its full supplier landscape, CAS number and patent status.

API / Drug Master Files

LINHAI TIANYU PHARMACEUTICAL CO LTD holds 12 active (12 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• CANDESARTAN CILEXETILActive2026-06-17
• VALSARTAN DISODIUM (PROCESS II)Active2025-09-29
• VALSARTAN DISODIUM (PROCESS III)Active2025-09-29
• FEBUXOSTATActive2025-08-05
• AZILSARTAN KAMEDOXOMILActive2025-07-23
• DAPAGLIFLOZINActive2025-01-09
• AZILSARTANActive2024-03-25
• TICAGRELORActive2024-03-19
• VILDAGLIPTINActive2024-03-14
• APIXABANActive2024-03-04
• SACUBITRIL VALSARTAN SODIUM (INTERNAL CODE: LCZ696)Active2024-01-27
• MONTELUKAST BACKONE DIOLActive2014-09-30

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to LINHAI TIANYU PHARMACEUTICAL CO LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.